| ²é¿´: 787 | »Ø¸´: 1 | ||
dilemmaly½ð³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
»®Ïß²¿·ÖÔõô·ÒëʲôÒâ˼£¿Ð»Ð»£¡ ÒÑÓÐ1È˲ÎÓë
|
| After submission of the IND, the sponsor must delay the use of the drug in human subjects for not less than 30 days from the date the FDA acknowledges the receipt of the application. An IND automatically goes into effect following this period unless the FDA notifies the sponsor that as a result of its review of the submission. it is waiving the period and the sponsor may initiate the study early or the investigation is being placed on a clinical hold. |
» ²ÂÄãϲ»¶
283Çóµ÷¼Á
ÒѾÓÐ20È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
²ÄÁϹ¤³Ì302·ÖÇóµ÷¼Á
ÒѾÓÐ17È˻ظ´
Ò»Ö¾Ô¸»ªÖÐũ΢ÉúÎ288·Ö£¬ÈýÄêʵÑé¾Àú
ÒѾÓÐ10È˻ظ´
»¯Ñ§¹¤³ÌÓë¼¼Êõ324µ÷¼Á
ÒѾÓÐ22È˻ظ´
273Çóµ÷¼Á
ÒѾÓÐ51È˻ظ´
²ÄÁϸ´ÊÔÇóµ÷¼Á
ÒѾÓÐ18È˻ظ´
Ò»Ö¾Ô¸211£¬»¯Ñ§Ñ§Ë¶£¬310·Ö£¬±¾¿ÆÖصãË«·Ç£¬Çóµ÷¼Á
ÒѾÓÐ24È˻ظ´
µ÷¼Á
ÒѾÓÐ9È˻ظ´
ÉúÎïѧµ÷¼Á ¿Éµ÷¼Áµ½ÉúÎïÓëÒ½Ò©
ÒѾÓÐ6È˻ظ´

sqlg888
Ìú³æ (ÕýʽдÊÖ)
- SFL-EPI: 1
- Ó¦Öú: 163 (¸ßÖÐÉú)
- ½ð±Ò: 4544.2
- ºì»¨: 27
- Ìû×Ó: 995
- ÔÚÏß: 191.8Сʱ
- ³æºÅ: 4176864
- ×¢²á: 2015-10-27
- רҵ: Ãñ×åҩѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
dilemmaly(¿Õλ´ú·¢): ½ð±Ò+3, ¸ÐлӦÖú 2016-06-24 14:55:04
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
dilemmaly(¿Õλ´ú·¢): ½ð±Ò+3, ¸ÐлӦÖú 2016-06-24 14:55:04
|
the investigation is being placed on a clinical hold¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¾ÍÊÇ˵£º The US FDA has placed a clinical hold on an investigational the drug for the treatment£¬¶ÔÕâ¸öÒ©µÄÁÙ´²¹Û²ìÒª×ö£¬ÇëÉêÇëÕߣ¨ÔÞÖúÈË£©¾¡Ôç×¼±¸£¬Æô¶¯ÊµÑé¡£ |
2Â¥2016-06-24 14:35:15













»Ø¸´´ËÂ¥